Healio6d
Pemivibart only option against ‘false reassurance’ of reduced SARS-CoV-2 virulence
The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...
The Scientist6d
New Technology Improves SARS-CoV-2 mRNA Vaccine-Induced Immune Responses
In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), which produce the SARS-CoV-2 spike protein to activate potent B and ...
Healio5d
Study: Multiple SARS-CoV-2 infections increase risk for long COVID
The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...
dailyUW.com1d
Five years of COVID-19: What we have learned about SARS-CoV-2 since the beginning of the pandemic
January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...
Medindia5d
Novel Vaccine Strategy Targets Future Coronaviruses
Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...
A new vaccine approach could help combat future coronavirus pandemics
A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
The Lancet16d
Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose
The cross-neutralising effects of COVID-19 vaccines given as prime–boost regimens have garnered much interest as SARS-CoV-2 has evolved. Several studies have shown that immunisation with heterologous ...
IFLScience8h
Joint Vaccine Against COVID-19 And Flu Provides Strong Protection In Early Tests
“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, there is no vaccine approved to simultaneously protect against both viral ...